The Impact of the COVID-19 Pandemic on Otitis Media.
COVID-19
otitis media
prevention
treatment
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
06 11 2022
06 11 2022
Historique:
received:
06
10
2022
revised:
31
10
2022
accepted:
04
11
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
15
11
2022
Statut:
epublish
Résumé
Otitis media is one of the most common diseases in children, with 80% of children experiencing it by the age of three years. Therefore, the resulting social burden is enormous. In addition, many countries still suffer from complications due to otitis media. Meanwhile, COVID-19 has affected many diseases, with otitis media being one of the most strongly affected. This review aims to find out how COVID-19 has affected otitis media and its significance. A series of measures brought about by COVID-19, including emphasis on personal hygiene and social distancing, had many unexpected positive effects on otitis media. These can be broadly classified into four categories: first, the incidence of otitis media was drastically reduced. Second, antibiotic prescriptions for otitis media decreased. Third, the incidence of complications of otitis media was reduced. Fourth, the number of patients visiting the emergency room due to otitis media decreased. The quarantine measures put in place due to COVID-19 suppressed the onset and exacerbation of otitis media. This has great implications for the treatment and prevention of otitis media.
Identifiants
pubmed: 36366555
pii: v14112457
doi: 10.3390/v14112457
pmc: PMC9696639
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Pediatrics. 2020 Oct;146(4):
pubmed: 32879032
BMC Fam Pract. 2015 Jul 07;16:82
pubmed: 26148678
Lancet Infect Dis. 2010 Mar;10(3):195-203
pubmed: 20185098
Front Pediatr. 2021 Sep 13;9:722483
pubmed: 34589455
Curr Allergy Asthma Rep. 2003 Jul;3(4):335-40
pubmed: 12791211
Antibiotics (Basel). 2021 Feb 18;10(2):
pubmed: 33670657
Health Qual Life Outcomes. 2010 Jul 26;8:75
pubmed: 20659326
Am J Emerg Med. 2021 Nov;49:142-147
pubmed: 34111834
J Pediatric Infect Dis Soc. 2021 Feb 13;10(1):62-64
pubmed: 33064837
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Front Cell Infect Microbiol. 2021 Nov 01;11:768377
pubmed: 34790591
Am J Otolaryngol. 2020 May - Jun;41(3):102487
pubmed: 32336572
Am J Emerg Med. 2021 May;43:115-117
pubmed: 33556796
Eur Arch Otorhinolaryngol. 2022 May;279(5):2671-2678
pubmed: 34807284
PLoS One. 2012;7(4):e36226
pubmed: 22558393
Infect Dis Now. 2021 Aug;51(5):418-423
pubmed: 33991720
Swiss Med Wkly. 2021 Oct 18;151:w30068
pubmed: 34668689
Otolaryngol Head Neck Surg. 2021 Nov;165(5):710-715
pubmed: 33494659
J Laryngol Otol. 2021 Jan;135(1):10-13
pubmed: 33407978
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Pediatrics. 2021 Apr;147(4):
pubmed: 33361360
Can Fam Physician. 2011 Jan;57(1):60-5
pubmed: 21252135
Laryngorhinootologie. 2022 May;101(5):414-418
pubmed: 34130328
Eur J Pediatr. 2021 Feb;180(2):649-652
pubmed: 32691131
Eur Arch Otorhinolaryngol. 2022 May;279(5):2383-2389
pubmed: 34218309
Pediatr Infect Dis J. 2020 Dec;39(12):e423-e427
pubmed: 32773660
PLoS One. 2014 Dec 29;9(12):e111732
pubmed: 25545891
Children (Basel). 2021 Aug 25;8(9):
pubmed: 34572160
Med Mal Infect. 2020 Feb;50(1):74-77
pubmed: 31843343
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):591-593
pubmed: 32407298
Curr Opin Pediatr. 2015 Feb;27(1):110-5
pubmed: 25514574
Otolaryngol Head Neck Surg. 2016 Feb;154(1 Suppl):S1-S41
pubmed: 26832942
J Prim Care Community Health. 2022 Jan-Dec;13:21501319221082351
pubmed: 35289210
Infect Drug Resist. 2014 Jan 10;7:15-24
pubmed: 24453496
Clin Infect Dis. 2008 Mar 15;46(6):815-23
pubmed: 18279042